Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 114

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 114
---
 financial resources will be sufficient to sustain its planned operations for at least the next twelve months.

<div align='center'>F-8</div>

REVIUM RX.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

U.S. dollars in thousands

NOTE 1– GENERAL (Cont.)

Predecessor

To date, Predecessor has not generated any revenue from its current operations and therefore is dependent upon external sources for financing
its operations. As of July 23, 2024, and December 31, 2023, the Company had an accumulated deficit of $3,343 and $1,922, respectively
Furthermore, the Company intends to continue to finance its operating activities by raising capital. As of December 31, 2023, the Predecessor
has raised approximately $3,109 and believes in order to realize its business plans. The Successor has declared it will continue financing
Predecessor Activity if needed. If the Predecessor will not have sufficient liquidity resources, the Company may not be able to continue
the development of its product or may be required to implement a cost reduction and may be required to delay part of its development programs.
Predecessor management and board of directors are of the opinion that its current financial resources and Successor finance will be sufficient
to continue the development of the Company’s products for at least the next twelve months.

| c. | Impact                              
 of the “Iron Swords” War on Israel: |

In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. In addition, Hezbollah have attacked military and civilian targets in Northern Israel, to which Israel has responded, including through increased air and ground operations in Lebanon. Since the war broke out, our subsidiary's operations have not been adversely affected by this situation, and we have not experienced disruptions to our development. However, the intensity and duration of Israel’s current war against Hamas and Hezbollah is difficult to predict at this stage, as are such war’s economic implications on the Company’s business and operations and on Israel’s economy in general.

The Company continues to monitor its ongoing activities and will make adjustments in its business if needed, including updating any estimates or judgments impacting its financial statements as appropriate.

NOTE 2–